Chapter 31: Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

So imagine a patient who can take a dose of pain medication large enough to literally kill a horse and they barely even blink.

But then imagine that same exact medication causing a fatal overdose in someone else simply because they decided to take a hot bath.

Welcome to the wildly unpredictable world of opioid pharmacology.

It really is wild because usually when we talk about a medical diagnosis there's this expectation of precision.

Like you break your arm, the x -ray shows a jagged white line, and it's a binary situation.

It's either broken or not broken.

Exactly.

But then you step into pain management and suddenly that x -ray machine is, well, it's completely useless.

We're looking at a clinical landscape that is entirely invisible to the naked eye.

So welcome to the steep dive.

We're treating you today as a nursing student tackling a massive pharmacology assignment.

A very heavy assignment.

Right, right.

And our mission is to master the clinical reasoning behind opioid analgesics, opioid antagonists, and non -opioids centrally acting analgesics, and we're pulling this directly from Chapter 31 of the Lens Pharmacology text.

Yeah, and the goal here is to really translate that incredibly dense drug information into plain practical language because, you know, memorizing a laundry list of side effects, that will not save your patient.

No, it won't.

Understanding the exact underlying mechanisms, like the actual cause and effect behind why those side effects happen, that is what makes a safe, effective nurse.

So let's unpack this from the very beginning.

The materials start by defining an analgesic.

And simply put, I mean, it's a drug that relieves pain without causing a loss of consciousness.

Right.

But before we even get to the medications in the pharmacy, we kind of have to look at the chemicals our own bodies make, right?

Because we produce our own built -in painkillers.

They're called endogenous opioid peptides.

Yeah.

The body has three main families of these peptides.

You've got your enkephalins, your endorphins, and dinorphins.

Right.

And they have opioid -like properties, and they're found naturally all throughout the central nervous system and peripheral tissues.

They basically serve as neurotransmitters and neuromodulators.

So the prescription drugs we're about to discuss, they don't really do anything entirely new, do they?

Not at all.

They essentially just hijack or mimic this naturally occurring system that's already there.

Right.

And to understand how these drugs hijack the system, we have to understand the specific blocks they fit into inside the body, the opioid receptors.

And I kind of like to think of these receptors like a VIP lounge at like a really exclusive nightclub.

Oh, I like that analogy.

Yeah.

So you have the Mu receptors, which act as the main VIP room where all the intense heavy hitting effects happen.

And then you have the Kappa receptors, which act as a smaller, maybe quieter side room.

How does that actually translate to the pharmacology?

Well, from a clinical perspective, those Mu receptors in your main VIP room, those are the primary target.

When a pure opioid agitist activates a Mu receptor, you get this massive rush of responses.

Like what?

Well, you get analgesia, which is the pain relief we obviously want.

But you also get respiratory depression, euphoria, and sedation.

Furthermore,

Mu activation is the pathway that is directly tied to physical dependence.

Oh, wow.

Okay.

So what happens if a drug only goes into that Kappa side room?

So activating Kappa receptors also produces analgesia and sedation, which is very helpful for pain relief.

It also causes decreased gastrointestinal motility.

Right.

However, Kappa activation does not cause the intense, dangerous respiratory depression or the euphoria that we see with the Mu receptors.

Okay.

Which brings us to the gold standard, right?

The prototype scheduled to pure opioid agonist, which is morphine.

The therapeutic goal is pretty straightforward.

It's the relief of moderate to severe pain.

Exactly.

But this is where we really have to dig into the adverse effects.

Because a nurse can't just memorize that morphine causes constipation, they have to know the mechanism.

Why does the gut completely stop working?

Because those Mu receptors, they aren't just in the brain.

They actually lie in the intestinal tract, too.

So activating them suppresses the propulsive intestinal contractions that normally move food along.

Oh, so it just paralyzes the gut.

Essentially, yeah.

At the same time, it intensifies non -propulsive spasms, and it actually increases the tone of the anal sphincter.

So it basically puts the gastrointestinal tract in a vice grip.

Yikes.

Okay.

Well, what about orthostatic hypotension?

Why does a patient get dangerously dizzy just by standing up out of bed?

So normally, when you stand up, your blood vessels constrict to keep blood pumping upward to your brain, right?

Right.

Morphine -like drugs blunt that bare receptor reflex, and they also cause a significant release of histamine.

Wait.

Histamine?

Like allergies?

Yeah, exactly.

And that histamine dilates the peripheral arterioles and veins, so the blood just simply pools in the lower extremities, which drops the blood pressure and causes that sudden dizziness.

That makes so much sense.

I also noticed the clinical guidelines heavily emphasize urinary retention, meiosis, and emesis.

What is actually happening in the body to cause those?

Well, urinary retention happens through a triple thread of mechanisms.

First, the drug increases tone in the bladder sphincter, acting like a closed valve.

Okay, that's one.

Right.

Second, it increases tone in the detrusor muscle, which elevates pressure within the bladder and causes this awful, constant sense of urgency.

Then the third.

Finally, it suppresses the patient's brain from even registering the bladder stimuli in the first place.

Oh, that's terrible.

And what about meiosis?

That's pinpoint pupils, right?

Exactly.

Meiosis refers to pinpoint pupils.

And then emesis, which is severe nausea and vomiting, that happens because opioids directly stimulate the chemoreceptor trigger zone, which is located in the medulla of the brain.

Okay.

And I know there's also a very real risk of birth defects if taken just before conception or during early pregnancy, but I want to talk about the absolute biggest risk, the one that flashes in bright red on every safety alert respiratory arrest.

What is the hard and fast nursing implication there?

It is absolutely the most serious adverse effect, and it's the leading cause of opioid -related death.

The nursing implication is completely non -negotiable.

You must assess vital signs before administering any opioid.

And what's the cutoff?

If the respiratory rate is less than 12 breaths per minute, you withhold the medication and immediately notify the healthcare provider.

Got it.

Okay, I want to push back on something, though, regarding how the body adapts to these drugs over time, because the materials differentiate between tolerance, physical dependence, and abuse liability.

Right.

They're very different concepts.

Yeah.

So if a patient takes opioids for a long time, they develop a tolerance, meaning they need larger doses to get that same pain relief.

But wait, if tolerance develops to the pain relief, doesn't it also develop to the deadly respiratory depression?

Yes.

So does that mean a cancer patient could survive a massive dose that would literally kill a person who has never taken an opioid?

Yes, and that is a crucial clinical reality to grasp.

Fortunately, as tolerance develops to the therapeutic effects like analgesia, it concurrently develops to the respiratory depression.

So a highly tolerant individual can take astronomical doses without a noticeable drop in their breathing rate.

Wow.

Okay.

However, and this is a big, however, very little tolerance develops to the constipation amniosis.

Oh, really?

Yeah.

A highly tolerant user will still struggle with severe constipation and will still present with constricted pupils even after years of use.

Okay.

So how does that contrast with physical dependence and abuse liability?

And I guess what does it look like when someone crosses the line into actual toxicity?

So physical dependence is a state where the body has made literal adaptive cellular changes to survive the continuous presence of the drug.

If you stop the drug abruptly, an abstinence syndrome, which is withdrawal, will occur because the cells are suddenly thrown into total chaos.

Right.

And abuse liability.

Abuse liability is tied to the drug's ability to cause pleasurable experiences like that euphoria, which creates psychological reinforcement.

Gotcha.

And for toxicity.

If someone takes too much and enters toxicity, we look for the classic triad.

That's coma, respiratory depression, and pinpoint pupils.

Coma, respiratory depression, pinpoint pupils.

Okay.

So if morphine is the gold standard and it works so well, why does a hospital pharmacy need dozens of other opioid options?

Like what do other drugs do that morphine can't?

Let's examine the strong and moderate agonists, starting with fentanyl, which the text says is roughly 100 times stronger than morphine.

Yeah, 100 times.

Because of that extreme potency, fentanyl is reserved for very specific situations.

It comes in transdermal patches for the skin, transmucosal forms like lozenges and IV formulations.

And for the transdermal patches, patient teaching is quite literally a matter of life and death.

It can take up to 24 hours for the full analgesic effects to develop, meaning the patient might actually need a short acting medication just to bridge that gap.

Oh, because the patch takes so long to kick in.

Exactly.

And when disposing of a patch, you have to fold it in half with the medication side touching itself and then flush it down the toilet.

And most critically, a patient must never apply direct heat to the patch.

Wait, why does heat matter so much?

Because heat massively accelerates the release of the fentanyl into the bloodstream.

A heating pad, sunbathing, or even just a natural fever can cause this sudden massive dump of the drug, leading to a fatal overdose.

Wait, if fentanyl is 100 times stronger than morphine and something as simple as a hot bath or a fever can kill a patient, why on earth are we sending people home with fentanyl patches?

It sounds crazy, I know, but transdermal fentanyl is indicated exclusively for persistent severe pain in patients who are already highly opioid tolerant.

You would never, ever give a fentanyl patch to an opiate -naive patient, and you never use it for acute intermittent pain like recovering from a routine surgery.

Furthermore, for the transbucosal formulations, the ones used for sudden breakthrough cancer pain, there is a heavily restricted distribution system called the TERF REMS program.

Wait, TERF REMS?

That sounds like a classified government password.

What does that actually mean for a nurse who is handing over the medication?

Alright, so TERF stands for Transbucosal Immediate Release Fentanyl.

And REM stands for Risk Evaluation and Mitigation Strategy.

It's an FDA -mandated safety program that ensures the benefits of a drug actually outweigh its risks.

Pharmacies, prescribers, and patients all have to be specially registered just to handle these specific fentanyl products.

Wow, they don't mess around with that.

Moving down the list of strong agonists, we have Meparidine and Methadone.

I see Meparidone is really falling out of favor in modern practice.

Why is that?

Well, when the liver breaks down Meparidine, it creates this toxic metabolite called Normaparidine.

And with continuous use, the kidney simply cannot clear it out fast enough.

It just builds up.

Exactly.

It accumulates in the blood and causes dysphoria, tremors, and even severe seizures.

Additionally, it has a highly fatal interaction with MAOIs, or monohymin oxidase inhibitors, which are the class of antidepressants.

What actually happens when those two mix?

So Meparidine blocks the reuptake of serotonin in the brain.

If a patient is on an MAOI, which already increases serotonin levels, the combination triggers serotonin syndrome.

Oh, I've heard of that!

Yeah, the brain is flooded with serotonin, leading to severe excitation, delirium, hypodermia, and potentially death.

Okay, so stay away from Meparidine if possible.

What about Methadone?

I mean, it's well known for treating pain and opioid addiction, but there is a massive red flag in the text for nursing monitoring.

Methadone uniquely prolongs the QT interval on the heart's electrical cycle.

This poses a very serious risk for potentially fatal cardiac dysrhythmias, specifically a chaotic rhythm called torsades de pointe.

So what does the NERTS do?

The critical nursing action is ensuring the patient receives a baseline electrocardiogram, or ECG, before starting treatment, then again 30 days later, and annually thereafter.

Okay, let's look at the moderate to strong agonists.

Coding is a classic, but its metabolism relies entirely on a liver enzyme called CYP2D6.

And this enzyme actually has to convert the coding into its active form, which is, strangely enough, morphine.

Yeah, this is where genetics completely dictate pain management.

About 10 % of each coding dose is converted to morphine in the liver.

However, some people lack an effective gene for the CYP2D6 enzyme entirely.

So what happens to them?

For them, coding is virtually a placebo.

It does absolutely nothing for their pain.

Conversely, there are— Wait, so it literally just doesn't work?

Exactly, no pain relief at all.

But conversely, there are ultra -rapid metabolizers who carry multiple copies of this gene.

They convert coding into morphine incredibly fast.

Which I imagine creates a sudden severe toxicity risk.

And the tech says this is especially dangerous for breastfed infants, right?

Because if a mother is an ultra -rapid metabolizer, the infant can be exposed to dangerously high, even fatal levels of morphine right through the breast milk.

Yes, exactly.

The clinical sources also highlight oxycodone, which has been reformulated into abuse deterrent pills,

and tapenta -dol, which is unique because it not only activates mu receptors, but also blocks the reuptape of norepinephrine to fight pain.

And that dual action concept brings us perfectly to the next class of drugs.

What happens when we want to partially block these receptors, or rip the opioids off the receptors entirely to save a life?

Right, so we use agonist antagonists like pentazocene and buprenorphine.

How do they work in our VIP lounge analogy?

Well, they act as antagonists at the mu receptors, meaning they essentially stand in the doorway of the main VIP room and block anyone from entering.

But they act as agonists at the kappa receptors, meaning they happily activate that quieter side room.

Oh, I see.

And because they block the main mu room, they actually have a ceiling to their respiratory depression.

Beyond a certain dose, no further depression occurs, which makes them much safer in that regard.

But there is a huge flashing warning light for nurses here regarding these drugs.

What happens if you give an agonist antagonist to a patient who is already physically dependent on a pure opioid agonist, like morphine?

You will instantly precipitate sudden acute withdrawal.

Because the agonist antagonist acts as a blocker at the mu receptor, it basically acts like a bulldozer.

Just clearing everything out.

Right.

It aggressively kicks the existing morphine off the receptors, which throws the patient's cells into an immediate violent crisis.

Okay, and then we have the pure antagonists, the lifesavers.

Specifically naloxone, which is widely known as Narcan.

It competitively blocks opioid receptors, just ripping the opioids away to reverse that toxic triad of coma, respiratory depression, and pinpoint pupils.

The pharmacokinetics here are totally vital for a nurse to anticipate.

Naloxone has a very short half -life, usually around two hours.

If you administer it to a patient who has overdosed on an opioid with a much longer half -life, the naloxone will wear off while the opioid is still circulating in their blood.

Meaning the patient wakes up, seems completely fine, and then two hours later just slips right back into a coma and stops breathing.

Precisely.

The nurse must continuously monitor the patient and just be prepared to administer repeated doses.

You also have to titrate it very carefully, especially for individuals with opioid use disorder.

Why titrate it?

Why not just give them a huge dose to be safe?

Because if you push a massive dose of naloxone all at once,

you will transport them from a state of poisoning to a state of severe agonizing withdrawal in a matter of seconds.

Ouch.

Okay.

The sources also cover peripheral antagonists like methylnaltrexone.

Going back to my VIP lounge analogy, methylnaltrexone is kind of like a bouncer that only works at the gastrointestinal nightclub.

It's chemically designed so it cannot cross the blood -brain barrier to enter the brain's VIP rooms.

Right.

Therefore, it blocks the opioid from binding in the gut, allowing the patient to finally have a bowel movement, but they still get to keep all their pain relief in the brain.

That is an excellent way to visualize it, yeah.

It is indicated specifically for opioid -induced constipation when standard laxatives fail and because it stays out of the brain, it does not precipitate withdrawal or diminish analgesia at all.

Okay.

We need to look at a unique non -opioid painkiller before we discuss real -world nursing application, and that is tramadol.

How does tramadol tackle pain differently?

Well, tramadol has a really fascinating dual mechanism.

It's a very weak, moo agonist, but it primarily works by blocking the uptake of norepinephrine and serotonin in the spinal neurons, which inhibits the transmission of pain impulses.

Okay.

But because it alters serotonin, it carries serious drug interactions, right, like combining it with SSRI's selective serotonin reuptake inhibitors or the MAOIs we discussed earlier, that can easily trigger that fatal serotonin syndrome.

Yes.

It also lowers the seizure threshold, so it is strictly avoided in patients with epilepsy.

There is also a black box warning regarding suicide.

Tramadol can cause severe respiratory and central nervous system depression when combined with other depressants, you know, like alcohol,

making it a highly lethal vehicle for intentional overdoses, especially in vulnerable depressed patients.

Which forces us to kind of zoom out and look at the broader clinical application here.

How does a nurse apply all this highly specific receptor knowledge in the real world, especially in the shadow of the opioid epidemic?

Yeah.

The clinical history provides vital context here.

In the 1990s, there was this massive cultural shift in medicine to treat pain as the fifth vital sign.

Hospitals were literally graded on how completely they eliminated a patient's pain, which led to incredibly aggressive opioid prescribing.

Right.

And that had consequences.

Huge consequences.

Fast forward to 2017, and the Department of Health and Human Services declared a national public health emergency.

This crisis led to the RIMS education programs we discussed earlier and the creation of abuse deterrent pill formulations.

Yeah.

For example, Oxycontin was reformulated so that if someone tries to crush it and dissolve it in water to inject it, it just turns into a thick useless gel.

Wow.

And amidst all this intense scrutiny, nurses still have an ethical and professional duty to assess and treat pain.

The challenge is the absolute subjectivity of pain and the complete lack of a standard dose.

We cannot measure pain with a blood pressure cuff or a thermometer.

No, we can't.

I want to challenge this concept a bit because it is a classic nursing dilemma.

Imagine a patient is sitting in their hospital bed.

They look completely fine.

They're scrolling on their phone, maybe laughing at a video, but they look up and rate their pain an 8 out of 10.

How does a nurse reconcile what they clearly observe with the mandate that pain is purely subjective?

I mean, it is the ultimate test of a nurse's clinical reasoning.

The foundational rule is this.

You have to trust the patient's report while assessing comprehensively.

Even if they look fine.

Especially them.

Patients might under report pain because they fear addiction or they just despise needles or they might try to look stoic to be a good patient.

Conversely, they might look entirely comfortable because they are using distraction like laughing at their phone as a powerful coping mechanism just to endure the pain.

That makes sense.

If you let your own bias dictate that they don't look like they're experiencing an 8 out of 10 pain level, you risk severely under treating them.

Okay, so to avoid the massive swings in pain levels that cause patients such distress,

the materials highlight patient controlled analgesia or PCA pumps because when a nurse gives a big intramuscular injection every four hours, it creates a dangerous roller coaster.

Very dangerous.

The patient hits a high peak of deep sedation and then crashes into a valley of severe agonizing pain as the drug wears off.

The PCA pump totally eliminates that roller coaster.

It allows the patient to push a button to deliver a very small preset IV bolus of medication like morphine.

This maintains a smooth, steady plasma level in the blood.

But they can't just spam the button, right?

Right.

It features strict lockout intervals, say 10 minutes, so the pump will not deliver another dose even if the patient pushes the button 50 times.

And there is a massive patient teaching point here regarding family members.

A family member must never push the PCA button while the patient is sleeping.

The safety mechanism relies entirely on the patient being awake enough to feel the pain and push the button.

If a well -meaning family member pushes it while the patient sleeps, they bypass the safety mechanism entirely and can easily cause a fatal respiratory overdose.

That's so critical.

Finally, we must recognize how opioid administration goals shift dramatically across the lifespan and for specific types of pain.

How so?

Well, for cancer pain,

maximizing comfort is the absolute priority.

Concerns about physical and psychological dependence are minimal.

No terminal patient should suffer because of a reluctance to use adequate opioids.

Right.

And for a myocardial infarction or a heart attack, morphine is the drug of choice.

But not just for the chest pain, right?

Morphine actively reduces cardiac work and oxygen demand by lowering blood pressure and decreasing venous return to the heart.

Exactly.

And for obstetrics, opioids can suppress uterine contractions and cross the placenta, which can cause severe respiratory depression in the neonate.

The nurse must monitor the newborn closely and literally have naloxone drawn up and ready.

It all comes back to anticipating the physiological response.

Knowing which receptors are activated, predicting the adverse effects, and managing the risks before they turn into actual emergencies.

That's nursing in a nutshell.

We have covered everything from the VIP lounge of Moo receptors to the mechanics of PCA pumps.

But I want to leave you with a forward -looking thought about precision medicine.

We talked about how codeine relies entirely on the CYP2D6 enzyme and how genetic variations make some people ultra -rapid metabolizers and others poor metabolizers.

Yeah, the genetic lottery.

Right.

So what if the future of nursing and pharmacology involves running a rapid genetic swab on every single patient before their very first dose of pain medication?

Imagine entirely eliminating the guesswork.

No more accidental infant toxicities.

No more wondering why a patient isn't getting relief.

Just pure, individualized, genetically tailored pharmacology.

It would completely transform how we understand that x -ray analogy from the beginning of our discussion.

We would finally have a clear binary picture of exactly how a patient's body will process the drug before we even open the vial.

Something to mull over as you prepare for your exams.

That is all for this deep dive.

A warm thank you from the last -minute lecture team.

We wish you the absolute best of luck mastering this material and applying it in your future clinical practice.

You've got this.